In Reply We thank Gerke et al for their interest in our article and appreciate the opportunity to address their concerns.
Black men are diagnosed more often with prostate cancer (PCa) than white men in the United States. Thus, even if PCa-specific mortality (PCSM) outcomes are similar, the disease burden is greater for black men. Our article did not address this important disparity.1 We stated that “our data do not address the biological propensity to develop an incident prostate cancer…which may contribute to the higher rate ratio of prostate cancer death in black men.”1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Dess RT, Mahal BA, Spratt DE. Biology vs Access to Care—Relative Contribution to Racial Disparities in Prostate Cancer—In Reply. JAMA Oncol. Published online October 31, 2019. doi:https://doi.org/10.1001/jamaoncol.2019.4509
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: